483 Ind-Swift Labs Mar 2017

483 Ind-Swift Labs Mar 2017

Saied Asbagh FDA$119.00 - Available Now

FDA investigators audited the Ind-Swift Labs - Mohali, India facility and issued inspectional observations (via FDA 483) on 24 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Mar 2017
  • Location: Mohali, India
  • FEI: 3005895238
Add To Cart